Review for Medical Staff, Naval Hospital Camp Pendleton Slides developed by CAPT M Ryan; Approved for Distribution and Training via ECOMS Varenicline (Chantix)

Slides:



Advertisements
Similar presentations
Community Pharmacy Workbook
Advertisements

COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
Case Examples.
Jim McCord, Project Director Tobacco Control Program SD DOH 615 E. 4 th St. Pierre, SD Phone: (605) Fax: (605)
Encouraging cessation intervention to become routine practice for people working with Aboriginal and Torres Strait Islander clients Toni Mason Aboriginal.
Nicotine Addiction Pharmacy Practice II Winter 2005.
Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
SETTING OUR COMPASS QuitlineNC: Partnering to Improve Tobacco Cessation in North Carolina.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Presented by: Asfiya Afsar Nadia Barak Catriona Hagley SMOKING CESSATION.
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
All About Smoking Cessation Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health.
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Smoking Cessation Pathway Reducing the infant mortality rate in Cincinnati and Hamilton County.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Safety Review for Plan B Daniel Davis, MD, MPH Division of Reproductive/Urologic Drugs.
CHANTIX (varenicline tartrate ) ROBERT A. SCHWARTZ Executive Vice President Managing Attorney - Houston Attorney in Charge of Mass Tort and Commercial.
GOOD PHARMACY PRACTICE
Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.
Medication History: Keeping our patients safe. How do we get all of the correct details?
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
The Ohio Partners for Smoke-Free Families 5A’s
Implementing NICE guidance
Healthy Air for Kids Campaign
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Fatima Chaudhry. Why this drug was developed According to the Centers for Disease Control and Prevention (CDC), an estimated 45 million adults in the.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
The Alabama Tobacco Quitline and July 22, 2010.
Cherokee Health Systems Encouraging Tobacco Cessation Through the Five A’s: Ask, Advise, Assess, Assist, Arrange Mary Clare Champion, Ph.D. Cherokee Health.
Smoking and Mental Health HWb workshop 9th July 2015 Emily Clarke Assistant Manager Hertfordshire Stop Smoking Service Liz Fisher Head.
Varenicline PGD flow chart Process for PGD accredited Pharmacists.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
Module 2: Learning Objectives
 1,400 Montanans die a year from a tobacco related disease  In 2009, 16% or approx 118,00 Montana adults were current smokers  In 2009, approx 50,000.
Attempting to increase the use of smoking cessation medications Brendon Baker Ministry of Health.
Accutane FDA (Section Name - Saver’s Initials) 3/9/00 12:50 PM 1 Risk Management Options Russell Ellison, MD Chief Medical Officer Vice President, Medical.
Smoking Cessation Services in a Baltimore County Title X Family Planning Program CityMatCH Urban Maternal and Child Health Leadership Conference Albuquerque,
Types of help Available NHS Stop Smoking Services Nicotine Replacement Therapy (NRT) Other Pharmacological Treatments (non nicotine) Alternative Therapies.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
1 A national initiative to help smokers quit: the English experience Robert West University College London Stockholm, April 2008.
Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw Published March 2017.
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
Smoking Cessation Medication
screening, brief intervention, and referral to treatment
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
FDA Authority to Regulate Tobacco Products Tobacco Control Act
Methotrexate in Psoriasis Shared Care Guidelines
Protocol References Section Title 6.2 Entry Visit 5.1
QuitlineNC Funding.
Tobacco Cessation Guidelines for COPD
Treating Tobacco Dependence
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Tobacco Cessation Coverage
Bruce Waslick, MD Medical Director UMass / Baystate MCPAP Team
Smoking cessation Felix K. Karthik.
Freshstart Facilitator Training
Supply Varenicline Under PGD
COMMUNITY PHARMACY WORKBOOK 2019 PUBLIC HEALTH DORSET
Fact About About Generic Zyban
Smoke-free policy Duke University will be a smoke-free campus beginning July 1, This means the use of all combustible tobacco products (tobacco.
Presentation transcript:

Review for Medical Staff, Naval Hospital Camp Pendleton Slides developed by CAPT M Ryan; Approved for Distribution and Training via ECOMS Varenicline (Chantix) Medication to Support Tobacco Cessation

Background and Summary Varenicline (Chantix) is a nicotinic receptor partial agonist. It reduces cravings and decreases pleasurable effects of nicotine. Approved by FDA in May 2006 for medical support of tobacco cessation. Sole manufacturer is Pfizer. Chantix has been available in the military health system since FDA approval, but its use has been inconsistent and controversial across DoD facilities. Credentialed providers should prescribe Chantix with great care, and generally as a 2 nd -line medical treatment. Chantix for Tobacco Cessation

Effectiveness Chantix appears to have clinical effectiveness equal to, or greater than, other medical treatments to support tobacco cessation. Classic alternative medical treatments include oral bupropion (Zyban or Wellbutrin) and nicotine replacement therapy (nicotine patches or gum, available with or without Rx). Nicotine replacement therapies and/or bupropion are generally considered “1 st -line” treatments under DoD/VA guidelines, and Chantix is considered a “2 nd -line” treatment. Chantix for Tobacco Cessation

Safety Common side effects of Chantix include: nausea – may be reduced by taking medication with food; sleep disturbance or vivid dreams – may be reduced by altering the timing of, or skipping, evening dose. Rare, serious side effects include mental health disturbances. Agitation, depression, and suicidal thoughts/actions have been reported. There were >30 suicide concerns reported among first 5 million users, although true incidence and relatedness to medication use have not been established. FDA issued an “Alert” on Chantix and mental health disturbances in early FDA “Boxed Warning” added to Chantix in FDA post-marketing surveillance is ongoing. Chantix for Tobacco Cessation

Military Considerations As per FAA and DoD, Chantix is not approved for use in flight status. Aviation professionals, including aircrew and air traffic controllers, must be “grounded” while taking Chantix, and cleared by flight surgeon before return to full duty. As per Army guidance, Chantix is not approved for use during deployment. Other services generally follow this guidance in theater. Providers should generally avoid Chantix prescribing to anyone with duties that prohibit use of psychotropic medications. These may include submariners, divers, explosive ordnance handlers/drivers, and others. Chantix for Tobacco Cessation

Prescribing Guidance Only credentialed providers should prescribe Chantix. The same provider should see patients for monthly follow-up. Initial encounter requires adequate time for interview and record review. Review all tobacco cessation support options. Establish motivation to quit and quit date with patient. Encourage use of formal Tobacco Cessation support class. Several options exist, including classes at NHCP (POC is Julius Phillips at ). Classes are not required, but strongly encouraged. Chantix for Tobacco Cessation

Prescribing Guidance (continued) If Chantix is prescribed, document counsel on all precautions, and provide patient hand-out. Ensure patient understanding that urgent care is required for any mental health challenges. Document that patient is not in flight status or planning deployment while on Chantix. Avoid use in pregnant or breastfeeding women. Document counsel on this issue. (Chantix is a Pregnancy-Category-C drug, that is unlikely to be approved for use in pregnancy. Chantix may be passed in breast milk, and may not be safe for infants.) Chantix for Tobacco Cessation

Prescribing Guidance (continued) Prescribe with extreme caution to patients with a history of mental health challenges or mental health medications. Although no diagnoses or prescriptions are absolute contraindications to Chantix, consultation with the treating mental health care provider is strongly advised. Note: Mental health side effects in Chantix users are possible without prior mental health diagnoses. Mental health side effects in Chantix users are possible after many weeks of use without initial problems. Chantix for Tobacco Cessation

Prescribing Guidance (continued) Chantix is dispensed in easy-to-follow blister packs. The 1 st month “starter pack” graduates initial dose up from 0.5 mg daily to 1 mg twice/daily. Subsequent “continuation packs” include monthly supplies of 1 mg twice/daily. Plan to see patients at least monthly while on Chantix. Each month supply should be given without refills to ensure follow-up. Recommended duration of treatment is 3 months. Patients may self-taper off Chantix at the end of 3 rd pack. If patients are successful in quitting tobacco, but having difficulty tapering off Chantix, consider continuing treatment for one month at a time, up to 12 months. Chantix for Tobacco Cessation

Prescribing Guidance (continued) Advise patients to take Chantix with food. Advise patients to take Chantix as directed. If doses are missed, however, do not take make-up doses. In general, do not take more than 1 pill at a time, or more than 2 pills in a day. Advise patients never to share Chantix pills with friends or family. Advise patients to avoid tobacco* or nicotine-containing products while on Chantix. * Nicotine exposure on Chantix will likely cause nausea and headache. Most providers recommend patients try to smoke few cigarettes in first week of Chantix; negative reinforcement may increase chance of cessation success. Chantix for Tobacco Cessation

Resources Prescribing providers must have access to: USPHS. Clinical Practice Guidelines: Treating Tobacco Use and Dependence, last updated May BUMED Tobacco Cessation Action Team (TCAT) Toolbox Patient hand-out, “Chantix – What you need to know” DoD Medication Safety Notice on Chantix, May 2008 Provider information on Chantix (Pfizer), updated July 2009 Chantix for Tobacco Cessation

1.Click above to notify you have reviewed the Chantix PowerPoint Presentation. 2.Mr. Phillips will enter your name into “completed” listing. Close Chantix for Tobacco Cessation Submit

Thank you, your information has been submitted. Chantix for Tobacco Cessation